MEN1 and neoplasm: A GTE and AFCE (Association Francophone de Chirurgie Endocrinienne) cohort study including 603 patients with MEN1-related dpNETs reported that the presence of ZES, tumor size > 2 cm, and age > 40 years were independently associated with an increased risk of metastases [67].